These reproducibility studies are also very heterogeneous in terms of anti-PD-L1 IHC clones and platforms, the natures of cancers, the number of cases and pathologists, the use of physical glass slides or digital ones, the need for exact quantification of positive cells, or the use of semiquantitative scales and different statistical methods. The gene discussed is CD274; the disease is cancer.